Eunice S Wang

Eunice S Wang

UNVERIFIED PROFILE

Are you Eunice S Wang?   Register this Author

Register author
Eunice S Wang

Eunice S Wang

Publications by authors named "Eunice S Wang"

Are you Eunice S Wang?   Register this Author

100Publications

2679Reads

26Profile Views

Incorporating FLT3 inhibitors in the frontline treatment of FLT3 mutant acute myeloid leukemia.

Authors:
Eunice S Wang

Best Pract Res Clin Haematol 2019 06 12;32(2):154-162. Epub 2019 May 12.

Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY, 14263, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2019.05.006DOI Listing
June 2019

Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.

N Engl J Med 2019 04;380(17):1628-1637

From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1815105DOI Listing
April 2019

Advancing treatment of acute myeloid leukemia: the future of FLT3 inhibitors.

Expert Rev Anticancer Ther 2019 Mar 6;19(3):273-286. Epub 2019 Feb 6.

a Leukemia Service, Department of Medicine , Roswell Park Comprehensive Cancer Center , Buffalo , NY , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14737140.2019.1
Publisher Site
http://dx.doi.org/10.1080/14737140.2019.1573679DOI Listing
March 2019

Mitochondrial hypoxic stress induces widespread RNA editing by APOBEC3G in natural killer cells.

Genome Biol 2019 02 21;20(1):37. Epub 2019 Feb 21.

Department of Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13059-019-1651-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383285PMC
February 2019

Combining blinatumomab with targeted therapy for BCR-ABL mutant relapsed/refractory acute lymphoblastic leukemia.

Leuk Lymphoma 2018 08 18;59(8):2011-2013. Epub 2017 Dec 18.

b Leukemia Service , Roswell Park Cancer Institute , Buffalo , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1411595DOI Listing
August 2018

All--retinoic-acid and arsenic trioxide induced remission in promyelocytic blast crisis.

Leuk Res Rep 2018 25;10:16-19. Epub 2018 Jul 25.

Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22130489183001
Publisher Site
http://dx.doi.org/10.1016/j.lrr.2018.07.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079565PMC
July 2018

High dose daunorubicin: New standard of care for FLT3 ITD mutant AML.

Leuk Res 2018 06 23;69:87-88. Epub 2018 Apr 23.

Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.04.011DOI Listing
June 2018

Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia.

Expert Rev Clin Pharmacol 2018 Jun 11;11(6):549-559. Epub 2018 Jun 11.

b Leukemia Service, Department of Medicine , Roswell Park Comprehensive Cancer Center , Buffalo , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2018.1478725DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661897PMC
June 2018

Advances in immunotherapy for acute myeloid leukemia.

Future Oncol 2018 Apr 15;14(10):963-978. Epub 2018 Mar 15.

Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0459DOI Listing
April 2018

Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs.

Cancer Res 2018 03 16;78(6):1431-1443. Epub 2018 Jan 16.

Department of Cell Stress Biology, Roswell Park Cancer Institute, Elm and Carlton St, Buffalo, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-2690DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856628PMC
March 2018

Common fungal infections in patients with leukemia.

Authors:
Eunice S Wang

Clin Adv Hematol Oncol 2017 May;15(5):352-354

Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
May 2017

Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia.

Leuk Res Rep 2017 14;7:36-39. Epub 2017 Apr 14.

Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lrr.2017.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402627PMC
April 2017

Spontaneous Remission in an Older Patient with Relapsed ITD Mutant AML.

Case Rep Hematol 2016 29;2016:1259759. Epub 2016 Dec 29.

Leukemia Service, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.

View Article

Download full-text PDF

Source
https://www.hindawi.com/journals/crihem/2016/1259759/
Publisher Site
http://dx.doi.org/10.1155/2016/1259759DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5227128PMC
December 2016

Guideline recommendations for the prophylaxis of invasive aspergillosis in AML.

Authors:
Eunice S Wang

Clin Adv Hematol Oncol 2016 Nov;14(11):876-879

Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
November 2016

Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia.

Expert Opin Investig Drugs 2016 Jul 21;25(7):771-80. Epub 2016 Apr 21.

a Department of Medicine , Roswell Park Cancer Institute , Elm and Carlton Streets, Buffalo , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2016.1175432DOI Listing
July 2016

Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia.

Blood Rev 2016 05 3;30(3):201-11. Epub 2015 Dec 3.

Leukemia Section, Department of Medicine, Roswell Park Cancer Institute,Elm and Carlton Streets, Buffalo, NY 14263, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2015.11.004DOI Listing
May 2016

Rituximab-refractory thrombotic thrombocytopenic purpura responsive to intravenous but not subcutaneous bortezomib.

Transfusion 2016 Apr 18;56(4):970-4. Epub 2016 Jan 18.

Department of Pathology and Laboratory Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.13465DOI Listing
April 2016

A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemia.

Leuk Res 2016 Apr 16;43:44-8. Epub 2016 Feb 16.

Department of Medicine, Roswell Park Cancer Institute, Elm & Carlton Sts, Buffalo, NY 14263, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2016.02.003DOI Listing
April 2016

Novel Approaches for the Interim Management of Relapsed/Refractory Acute Lymphocytic Leukemia: A Case-Study Compendium.

Clin Adv Hematol Oncol 2016 Mar;14(3 Suppl 4):1-23

Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
March 2016

Polo-like kinase inhibitors in hematologic malignancies.

Crit Rev Oncol Hematol 2016 Feb 4;98:200-10. Epub 2015 Nov 4.

Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2015.10.013DOI Listing
February 2016

Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy.

Blood Rev 2015 Jul 10;29(4):243-9. Epub 2015 Jan 10.

Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2015.01.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494870PMC
July 2015

Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid Leukemia.

Clin Lymphoma Myeloma Leuk 2015 Jun;15 Suppl:S73-9

Leukemia Service, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.02.033DOI Listing
June 2015

Novel Management Options for Adult Patients With Progressive Acute Lymphoblastic Leukemia: A Case-Study Compendium.

Clin Adv Hematol Oncol 2015 Jun;13(6 Suppl 7):1-23

Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
June 2015

Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia.

Am J Hematol 2015 May 27;90(5):E77-9. Epub 2015 Feb 27.

School of Medicine, Department of Internal Medicine, University of Maryland Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23965DOI Listing
May 2015

Bosutinib for the Treatment of Philadelphia Chromosome-Positive Leukemias.

Expert Opin Orphan Drugs 2015 16;3(5):599-608. Epub 2015 Apr 16.

Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/21678707.2015.1036027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684277PMC
April 2015

How we will treat chronic myeloid leukemia in 2016.

Blood Rev 2015 Mar 17;29(2):137-42. Epub 2014 Dec 17.

Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2014.12.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385463PMC
March 2015

Pharmacological targeting of β-catenin in normal karyotype acute myeloid leukemia blasts.

Haematologica 2015 Feb 7;100(2):e49-52. Epub 2014 Nov 7.

Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.113118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803144PMC
February 2015

An oncologist's perspective on metformin use and acute lymphoblastic leukemia outcomes.

J Pharm Pract 2015 Feb;28(1):46-7

Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0897190014557627DOI Listing
February 2015

Revisiting the role of cladribine in acute myeloid leukemia: an improvement on past accomplishments or more old news?

Am J Hematol 2015 Jan 25;90(1):62-72. Epub 2014 Oct 25.

Department of Pharmacy, Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23862DOI Listing
January 2015

Treating acute myeloid leukemia in older adults.

Authors:
Eunice S Wang

Hematology Am Soc Hematol Educ Program 2014 Dec 18;2014(1):14-20. Epub 2014 Nov 18.

Leukemia Service, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2014.1.14DOI Listing
December 2014

Omacetaxine mepesuccinate in chronic myeloid leukemia.

Expert Opin Pharmacother 2014 Nov;15(16):2397-405

Roswell Park Cancer Institute, Department of Medicine, Leukemia Section , Elm and Carlton Street, Buffalo, NY 14263 , USA +001 716 845 8447 ; +001 716 845 2343 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2014.964642DOI Listing
November 2014

Deletion and deletion/insertion mutations in the juxtamembrane domain of the FLT3 gene in adult acute myeloid leukemia.

Leuk Res Rep 2014 16;3(2):86-9. Epub 2014 Oct 16.

Molecular Diagnostics Laboratory, Department of Pathology and Laboratory Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lrr.2013.09.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220013PMC
November 2014

Early versus late preemptive allogeneic hematopoietic cell transplantation for relapsed or refractory acute myeloid leukemia.

Biol Blood Marrow Transplant 2014 Sep 24;20(9):1369-74. Epub 2014 May 24.

Department of Medicine, BMT Program, Roswell Park Cancer Institute, Buffalo, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.05.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292802PMC
September 2014

High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failure.

Leuk Res Rep 2014 30;3(2):62-6. Epub 2014 Jul 30.

Department of Pharmacy, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lrr.2014.07.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145165PMC
September 2014

Long-term response of refractory primary cold agglutinin disease to eculizumab therapy.

Ann Hematol 2014 Feb 31;93(2):343-4. Epub 2013 May 31.

Department of Medicine, State University of New York at Buffalo, Buffalo, NY, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-013-1800-7DOI Listing
February 2014

Activity of the hypoxia-activated prodrug, TH-302, in preclinical human acute myeloid leukemia models.

Clin Cancer Res 2013 Dec 2;19(23):6506-19. Epub 2013 Oct 2.

Authors' Affiliations: Departments of Medicine, Immunology, Roswell Park Cancer Institute, Buffalo, New York; and Threshold Pharmaceuticals Inc, South San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0674DOI Listing
December 2013

Acute myeloid leukemia, version 2.2013.

J Natl Compr Canc Netw 2013 Sep;11(9):1047-55

From 1City of Hope Comprehensive Cancer Center; 2Memorial Sloan-Kettering Cancer Center; 3Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 4Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 5Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 6Stanford Cancer Institute; 7Massachusetts General Hospital Cancer Center; 8University of Alabama at Birmingham Comprehensive Cancer Center; 9UCSF Helen Diller Family Comprehensive Cancer Center; 10Moffitt Cancer Center; 11UNMC Eppley Cancer Center at The Nebraska Medical Center; 12The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 13St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 14Fox Chase Cancer Center; 15Duke Cancer Institute; 16The University of Texas MD Anderson Cancer Center; 17Huntsman Cancer Institute at the University of Utah; 18The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 19Dana-Farber Cancer Institute; 20Vanderbilt-Ingram Cancer Center; 21Roswell Park Cancer Institute; and 22National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161234PMC
http://dx.doi.org/10.6004/jnccn.2013.0127DOI Listing
September 2013

Myelodysplastic syndromes and autoimmune diseases--case series and review of literature.

Leuk Res 2013 Aug 18;37(8):894-9. Epub 2013 May 18.

Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2013.04.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699612PMC
August 2013

Development of a preclinical PK/PD model to assess antitumor response of a sequential aflibercept and doxorubicin-dosing strategy in acute myeloid leukemia.

AAPS J 2013 Jul 3;15(3):662-73. Epub 2013 Apr 3.

PK/PD Core Facility, Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1208/s12248-013-9480-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691438PMC
July 2013

Image cytometry-based detection of aneuploidy by fluorescence in situ hybridization in suspension.

Cytometry A 2012 Sep 26;81(9):776-84. Epub 2012 Jul 26.

Flow and Image Cytometry Laboratory, Department of Pathology and Laboratory Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.a.22101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384178PMC
September 2012

Phase 1 trial of linifanib (ABT-869) in patients with refractory or relapsed acute myeloid leukemia.

Leuk Lymphoma 2012 Aug 1;53(8):1543-51. Epub 2012 Mar 1.

Leukemia Service, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.660631DOI Listing
August 2012

Acute myeloid leukemia secondary to oxaliplatin treatment for esophageal cancer.

Clin Colorectal Cancer 2012 Jun 1;11(2):151-4. Epub 2011 Dec 1.

Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2011.09.002DOI Listing
June 2012

Smoking adversely affects survival in acute myeloid leukemia patients.

Int J Cancer 2012 Mar 2;130(6):1451-8. Epub 2011 Aug 2.

Department of Medicine, Leukemia Section, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.26151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202035PMC
March 2012

Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.

J Oncol Pharm Pract 2012 Mar 26;18(1):91-6. Epub 2011 Apr 26.

Department of Pharmacy, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155211402107DOI Listing
March 2012

Is obesity a prognostic factor for acute myeloid leukemia outcome?

Ann Hematol 2012 Mar 21;91(3):359-65. Epub 2011 Sep 21.

Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-011-1319-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469945PMC
March 2012

Myeloid blastic transformation of myeloproliferative neoplasms--a review of 112 cases.

Leuk Res 2011 May 19;35(5):608-13. Epub 2010 Aug 19.

Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S014521261000374
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2010.07.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017628PMC
May 2011

Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia.

Leuk Res 2011 May 21;35(5):579-84. Epub 2010 Dec 21.

Department of Pathology and Laboratory Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2010.10.020DOI Listing
May 2011

Interpretation of cytogenetic and molecular results in patients treated for CML.

Blood Rev 2011 May 17;25(3):139-46. Epub 2011 Mar 17.

Roswell Park Cancer Institute, Buffalo, NY 14263, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2011.02.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071443PMC
May 2011

Philadelphia chromosome-positive acute lymphoblastic leukemia: current treatment and future perspectives.

Cancer 2011 Apr 8;117(8):1583-94. Epub 2010 Nov 8.

Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25690DOI Listing
April 2011

Vascular endothelial growth factor inhibition: conflicting roles in tumor growth.

Cytokine 2011 Feb 13;53(2):115-29. Epub 2010 Aug 13.

Department of Cell Stress Biology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cyto.2010.06.012DOI Listing
February 2011

Interferon-γ secretion by t(9;22) acute lymphoblastic leukemia-derived dendritic cells.

Leuk Res 2011 Feb 12;35(2):275-7. Epub 2010 Oct 12.

Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01452126100044
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2010.09.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021772PMC
February 2011